Member Login
  1. Stocks
    2. /
  2. Hims & Hers Health (NYSE: HIMS)
    3. /

NYSE:HIMS (Hims & Hers Health)

About HIMS

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Hims & Hers Health (NYSE: HIMS) Latest News

Investing Articles

My top 2 disruptive growth stocks to consider buying in 2026

| Ben McPoland

Looking for stocks to buy? Find out why our writer likes this pair of explosive growth shares that have been…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

1 growth firm to consider for a Stocks and Shares ISA at $48!

| Ben McPoland

Our writer explains why he's bullish on this healthcare disruptor in his Stocks and Shares ISA, despite it whipsawing wildly…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

This growth stock just crashed 35%! Time to buy it for my Stocks and Shares ISA?

| Ben McPoland

Hims & Hers (NYSE:HIMS) stock collapsed yesterday, leaving this Fool to wonder if he should add it to his Stocks…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

3 growth stocks that have rocketed more than 100% in 2025! 

| Ben McPoland

Our writer takes a look at three red-hot growth stocks that have more than doubled this year to see if…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

UK stock investors are piling into this under-the-radar share up 270%! Should I join them?

| Ben McPoland

This writer noticed that UK stock investors have been buying an obscure share that fell 26% yesterday but is still…

Read more »